1. Home
  2. ETON vs ORN Comparison

ETON vs ORN Comparison

Compare ETON & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.80

Market Cap

411.9M

Sector

Health Care

ML Signal

HOLD

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$11.72

Market Cap

415.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
ORN
Founded
2017
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
411.9M
415.4M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
ETON
ORN
Price
$16.80
$11.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$31.00
$16.25
AVG Volume (30 Days)
298.4K
423.3K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
220.00
EPS
N/A
0.06
Revenue
$39,011,000.00
$852,260,000.00
Revenue This Year
$107.23
$7.08
Revenue Next Year
$29.72
$9.52
P/E Ratio
N/A
$197.33
Revenue Growth
23.29
7.01
52 Week Low
$11.09
$4.64
52 Week High
$23.00
$15.00

Technical Indicators

Market Signals
Indicator
ETON
ORN
Relative Strength Index (RSI) 49.63 37.14
Support Level $16.04 $8.18
Resistance Level $17.59 $13.17
Average True Range (ATR) 1.05 0.86
MACD -0.08 -0.31
Stochastic Oscillator 6.21 12.64

Price Performance

Historical Comparison
ETON
ORN

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: